MD MEDICAL GROUP ANNOUNCES LISTING ON THE MOSCOW EXCHANGE

5 November 2020, Moscow – MD Medical Group Investments Plc (“MD Medical Group”, “MDMG” or the “Company” – LSE: MDMG), a leading Russian private healthcare provider, announces that it has received approval for the listing of the Company’s Global Depositary Receipts (GDRs) (ISIN US55279C2008) on the MOEX and their inclusion into the Level 1 quotation list. The first day of trading is scheduled for November 9 2020. The trading ticker is MDMG. Quotation will be done in Russian rubles. 

The listing on the Moscow Exchange will be done of the MD Medical Group Investments Plc shares in the form of GDRs which currently trade on the London Stock Exchange. The listing in Moscow does not require an issue of new shares and will allow the Company’s existing GDRs to be traded also on the Moscow Exchange. 

Neither the Company, nor its shareholders are not placing GDRs and this release is not an offer to buy or sell the shares of the Company. 

It is expected that the listing on the Moscow Exchange will provide the Company access to a broader pool of investors, including Russian institutional and retail investors, who are well familiar with the Company’s brand. The Company expects that the listing will promote liquidity of the GDRs on both trading platforms. 

The ceremony, launching the start of trading with the participation of the CEO of MD Medical Group Mark Kurtser and top executives from the Moscow Exchange, will take place on November 9 2020 at 9-45 Moscow time and will be broadcast on the MOEX website.